Le Lézard
Classified in: Science and technology
Subjects: PDT, ACC

MAG Interactive AB (publ) publishes the Annual Report for 2021/2022


MAG Interactive AB (publ) has today published the Annual Report for 2020/2021 on the company's website

STOCKHOLM, Dec. 20, 2022 /PRNewswire/ -- MAG Interactive AB's (publ) annual report for the financial year 2021/2022 has today been published on the company's website: https://www.maginteractive.com/investors/investor-relations/reports/

The Annual Report is published in Swedish and English, and available as PDF.

For additional information, please contact:
Daniel Hasselberg / CEO / +46 (0)8 644 35 40 / [email protected]
Magnus Wiklander / CFO / +46 (0)8 644 35 40 / [email protected]

The following files are available for download:

https://mb.cision.com/Main/16579/3686868/1746848.pdf

MAG Interactive Annual Report ENG 21-22


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: